{"abstract": "As part of the deal, Celgene will acquire 9.1 million shares of Juno, a leader in cancer drugs that use patients\u2019 immune systems to attack tumors.", "web_url": "https://www.nytimes.com/2015/06/30/business/celgene-to-pay-1-billion-for-biotech-collaboration-with-juno.html", "snippet": "As part of the deal, Celgene will acquire 9.1 million shares of Juno, a leader in cancer drugs that use patients\u2019 immune systems to attack tumors.", "lead_paragraph": "Celgene, a leading biotech company, said on Monday that it would pay about $1 billion to start a collaboration with Juno Therapeutics, a leader in the hot new area of cancer drugs that harness patients\u2019 immune systems to attack tumors.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/06/30/business/30IMMUNE/30IMMUNE-articleLarge.jpg", "height": 414, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2015/06/30/business/30IMMUNE/30IMMUNE-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 414}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/06/30/business/30IMMUNE/30IMMUNE-jumbo.jpg", "height": 707, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/06/30/business/30IMMUNE/30IMMUNE-superJumbo.jpg", "height": 1330, "width": 1927, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2015/06/30/business/30IMMUNE/30IMMUNE-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2015/06/30/business/30IMMUNE/30IMMUNE-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/06/30/business/30IMMUNE/30IMMUNE-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Celgene to Pay $1 Billion for Biotech Collaboration With Juno", "kicker": null, "content_kicker": null, "print_headline": "Celgene to Pay $1 Billion for Juno Collaboration", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Celgene Corporation", "rank": 1, "major": "N"}, {"name": "persons", "value": "Pollack, Andrew", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Juno Therapeutics Inc", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 4, "major": "N"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "rank": 5, "major": "N"}, {"name": "subject", "value": "Cancer", "rank": 6, "major": "N"}, {"name": "subject", "value": "Tumors", "rank": 7, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 8, "major": "N"}], "pub_date": "2015-06-29T22:10:30+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/2edf1930-1b99-5711-92c6-65d435af39b6", "word_count": 708, "uri": "nyt://article/2edf1930-1b99-5711-92c6-65d435af39b6"}